Literature DB >> 27435747

A USPIO doped gel phantom for R2* relaxometry.

Gregory C Brown1, Gary J Cowin2, Graham J Galloway3.   

Abstract

OBJECTIVE: This work describes a phantom containing regions of controlled R2* (1/T2*) values to provide a stable reference object for testing implementations of R2* relaxometry commonly used for liver and heart iron assessments.
MATERIALS AND METHODS: A carrageenan-strengthened gadolinium DTPA doped agarose gel was used to enclose nine gels additionally doped with ultra-small superparamagnetic iron oxide. R2* values were determined at 1.5 T using multi-echo GRE sequences and exponential regression of pixel values from a region of interest against echo time using non-linear regression algorithms. We measured R2*, R2 and R1 values and the inter-scan and inter-operator reproducibility.
RESULTS: The phantom reliably demonstrated R2* values in seven steps between 22.4 s-1 (SE 1.98) and 441.9 s-1 (SE 6.76), with an R2* relaxivity (r2*) of 792 (SE 5.6) mM-1 s-1. The doped gels displayed a concentration-dependent R2' component of R2* phantom, indicating superparamagnetic enhancement effects. We observed no significant change in relaxivity (r2*) over 12 months, and estimate a useful life of 3 years. Detailed descriptions of the production process and calculators are been provided as Online Resources.
CONCLUSION: The phantom provides a durable test object with controlled R2* relaxation behaviour, useful for a range of R2* relaxometry reference work.

Entities:  

Keywords:  Calibration; MRI; Phantom imaging; Quantitative evaluation

Mesh:

Substances:

Year:  2016        PMID: 27435747     DOI: 10.1007/s10334-016-0576-x

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  47 in total

1.  Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques.

Authors:  H L Bonkovsky; R B Rubin; E E Cable; A Davidoff; T H Rijcken; D D Stark
Journal:  Radiology       Date:  1999-07       Impact factor: 11.105

2.  Low-frequency low-field magnetic susceptibility of ferritin and hemosiderin.

Authors:  P D Allen; T G St Pierre; W Chua-anusorn; V Ström; K V Rao
Journal:  Biochim Biophys Acta       Date:  2000-02-21

3.  Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease.

Authors:  John C Wood; J Michael Tyszka; Susan Carson; Marvin D Nelson; Thomas D Coates
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

Review 4.  The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds.

Authors:  J F Schenck
Journal:  Med Phys       Date:  1996-06       Impact factor: 4.071

5.  Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia.

Authors:  Dudley J Pennell; John B Porter; Maria Domenica Cappellini; Amal El-Beshlawy; Lee Lee Chan; Yesim Aydinok; Mohsen Saleh Elalfy; Pranee Sutcharitchan; Chi-Kong Li; Hishamshah Ibrahim; Vip Viprakasit; Antonis Kattamis; Gillian Smith; Dany Habr; Gabor Domokos; Bernard Roubert; Ali Taher
Journal:  Blood       Date:  2009-12-08       Impact factor: 22.113

6.  Deferasirox for cardiac siderosis in β-thalassaemia major: a multicentre, open label, prospective study.

Authors:  Antonio Piga; Filomena Longo; Raffaella Origa; Simona Roggero; Francesca Pinna; Antonietta Zappu; Chiara Castiglioni; Maria Domenica Cappellini
Journal:  Br J Haematol       Date:  2014-06-30       Impact factor: 6.998

7.  Intercentre reproducibility of magnetic resonance T2* measurements of myocardial iron in thalassaemia.

Authors:  Mark A Westwood; David N Firmin; Matta Gildo; Galanello Renzo; Gotsis Stathis; Karagiorga Markissia; Berdoukas Vasili; Dudley J Pennell
Journal:  Int J Cardiovasc Imaging       Date:  2005-10       Impact factor: 2.357

8.  A single breath-hold multiecho T2* cardiovascular magnetic resonance technique for diagnosis of myocardial iron overload.

Authors:  Mark Westwood; Lisa J Anderson; David N Firmin; Peter D Gatehouse; Clare C Charrier; Beatrix Wonke; Dudley J Pennell
Journal:  J Magn Reson Imaging       Date:  2003-07       Impact factor: 4.813

9.  Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major.

Authors:  Olympia Papakonstantinou; Efthymia Alexopoulou; Nikos Economopoulos; Odysseas Benekos; Antonis Kattamis; Stavroula Kostaridou; Vasilis Ladis; Efstathios Efstathopoulos; Athanassios Gouliamos; Nikolaos L Kelekis
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

10.  Cardiovascular function and treatment in β-thalassemia major: a consensus statement from the American Heart Association.

Authors:  Dudley J Pennell; James E Udelson; Andrew E Arai; Biykem Bozkurt; Alan R Cohen; Renzo Galanello; Timothy M Hoffman; Michael S Kiernan; Stamatios Lerakis; Antonio Piga; John B Porter; John Malcolm Walker; John Wood
Journal:  Circulation       Date:  2013-06-17       Impact factor: 29.690

View more
  1 in total

1.  MRI Relaxometry for Quantitative Analysis of USPIO Uptake in Cerebral Small Vessel Disease.

Authors:  Michael J Thrippleton; Gordon W Blair; Maria C Valdes-Hernandez; Andreas Glatz; Scott I K Semple; Fergus Doubal; Alex Vesey; Ian Marshall; David E Newby; Joanna M Wardlaw
Journal:  Int J Mol Sci       Date:  2019-02-12       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.